Members Only Content
Subscribe to get full access
Free Preview
The genetic infrastructure platform seems to have market underperformance written into its DNA. It's time we parted with our shares.
Upstart Recommendation Report Upstart Presentation Slides
Lemonade (NYSE: LMND) is a new player who's really adding zest to the insurance industry. Its AI-powered underwriting enables it to [...]
PubMatic just reported first quarter 2025 results. Aside from the headwinds of a DSP partner changing its bidding process, the [...]
